FDA Investigator Neali H Lucas

Neali H Lucas has inspections in 6 countries as of 06 Oct 2023. Neali H Lucas has collaborated with a combinined 2931 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Brazil, Argentina, India, Dominican Republic, France
Abdul K Kamara, Adam J Taylor, Adam J Wilson, Alanna Lmussawwir Bias, Amy S Graf, Andrace Lde Yampert, Andrea D Swingle, Angela J Alexander, Anthony R Petriella, Art O Czabaniuk, Ashley E Lewis, Barbara A Rusin, Barbara D Bennett, Barbara D Wright, Bei Y He, Benjamin J Smith, Bernard P Heidt, Bleta Vuniqi, Brandi N Mcgrady, Brentley S Collins, Brian P Putz, Bruce, Byron Ho, DVM, Byungja E Marciante, Calvin K Cook, Caroline H Le, Catherine V Quinlan, CDR Kimberly Y Martin, CDR Thomas R Berry, PPh, Charles I Ann, Charles L Zhou, Constantin Y Philopoulos, Corrine M Carter, Crystal M Young Lewis, Daniel J Gorski, Danielle S Mills, David A Paterson, Debara R Reese, Debara Reese, Debra D Devlieger, Denise L Burosh, Dennis E Guilfoyle, PhD, Dina A Tallman, Donald C Obenhuber, PhD, Emest F Bizjak, Emily B Camire, Emily J Orban, Erma Zaimova, Gabryelle J Solverud, Gary Durbiel Goldner, Hartman, Herbert M Corbello, Hokenson, Jacob A Clark, Jean Blackston Hill, Jean Blackstone Hill, Jeannie M Melin, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer C Adams, Jennifer C Johnson, Joel D Martinez, John A Iwen, John D Jaworski, Joseph A Piechocki, Joseph R Strelnik, Judith A Jankowski, Karen M Montgomery (KMM), Kathryn A Cutajar, Kathryn A Guardiola, Kecia M Smith, Kelley L Clark, Kristina Mezin, Kristina Nastovski, L Gnnmassimia Massimilla, PharmD, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Burke, Lauren E Sexton, Lauren Iacono Connors, PhD, Laurie A Haxel, LCDR Anastasia Mpiliafas Brown, Leigh Anne Myers, Lillian C Hsu, Linda S Jozefiak, Lisa M Bellows, Lisa M Thursam, Lisa P Oakes, Lisa Pierce Oakes, LTJG Aaron B Otis, Luella J Rossi, Marcus L Head, Margaret N Klug, Margaret N Persich, Marlon K Turner, Martin R Vowell, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Mercy Oyugi, Michael A Moutray, Michael Shanks, MS, Michele L Forster, PhD, Michelle L Jones, Mikhail V Ovanesov, PhD, Minh D Phan, Montgomery Montgomery, Karen M, Muna Algharibeh, Myra K Casey, Nailing Zhang, Nancy A Bellamy, Owens, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patsy J Domingo, Phenicia T Petty, Qiao Y Bobo, Rafeeq A Habeeb, Rasha Bamieh, Raymond T Oji, Rebecca E Dombrowski, Rebecca T Davis, Reginald Walker, Renee L Rice, PhD, Robert D Tollefsen, Robert J Ham, Robert M Barbosa, Rosia E Nesbitt, Ryan J Benedict, Saikat I Bhuiyan, Sandra A Boyd, Sanket N Patel, Sherri J Blessman, Sherri J Jackson, Sherri N Rohlf, MD, Sonya M Lambkin, State Agency, Susan F Laska, MS, Susan M North, Susan P Bruederle, Suyang Qin, Thai D Truong, Thomas J Arista, Thomas R Withers, Thuy T Nguyen, LCDR, Tina M Pawlowski, Tracey L Siebesma, Travis S Bradley, Twana R Chandler, Tyra L Vanleer, Uruaku A Obasi, Vesa Vuniqi, Victoria A Murray, Wayne E Seifert, William D Bassett, Jr, William D Tingley, Yangmin Ning, Yumi J Hiramine, Zoey A Trombley

Neali H Lucas's Documents

Publish Date Document Type Title
December, 2014 EIR Arnold S. Monto, M.D. - EIR, 2014-12-11
October, 2012 EIR Roland L. Chu, M.D. - EIR, 2012-10-02
April, 2015 EIR St Joseph Mercy Oakland Instiutional Review Board - EIR, 2015-04-21
April, 2015 FDA 483 Response St Joseph Mercy Oakland Instiutional Review Board - Form 483R, 2015-05-05
September, 2015 FDA 483 Michigan State University IRB - Form 483, 2015-09-02
September, 2015 EIR Michigan State University IRB - EIR, 2015-09-02
April, 2011 FDA 483 Covenant Medical Center Inc. - Form 483, 2011-04-20
July, 2016 FDA 483 Response Berhane nmi Seyoum, M.D. - Form 483R, 2016-07-27
August, 2012 FDA 483 Response Steven W. Pipe, M.D. - Form 483R, 2012-09-07
April, 2015 FDA 483 St Joseph Mercy Oakland Instiutional Review Board - Form 483, 2015-04-21
August, 2012 FDA 483 Satyaprakash N. Makam, MD - Form 483, 2012-09-13
April, 2011 EIR Covenant Medical Center Inc. - EIR, 2011-04-20
September, 2011 FDA 483 Response Satyaprakash N. Makam, MD - Form 483R, 2011-10-05
March, 2016 EIR Opada Alzohaili, M.D. - EIR, 2016-03-29
May, 2014 FDA 483 Satyaprakash N. Makam, MD - Form 483, 2014-05-23
August, 2012 FDA 483 Steven W. Pipe, M.D. - Form 483, 2012-08-17
September, 2011 FDA 483 Satyaprakash N. Makam, MD - Form 483, 2011-09-22
March, 2016 FDA 483 Opada Alzohaili, M.D. - Form 483, 2016-03-29
September, 2011 EIR Satyaprakash N. Makam, MD - EIR, 2011-09-22
December, 2011 FDA 483 Clarita S. Ketels, D.O. - Form 483, 2011-12-02
July, 2016 FDA 483 Berhane nmi Seyoum, M.D. - Form 483, 2016-07-11
November, 2015 FDA 483 Fahd Al-Saghir, MD - Form 483, 2015-11-06
July, 2016 EIR Berhane nmi Seyoum, M.D. - EIR, 2016-07-11
May, 2014 FDA 483 Response Satyaprakash N. Makam, MD - Form 483R, 2014-06-04
December, 2014 FDA 483 Arnold S. Monto, M.D. - Form 483, 2014-12-11
August, 2012 FDA 483 Response Satyaprakash N. Makam, MD - Form 483R, 2012-09-17
May, 2014 EIR Satyaprakash N. Makam, MD - EIR, 2014-05-23
August, 2012 EIR Steven W. Pipe, M.D. - EIR, 2012-08-17
April, 2011 FDA 483 Response Covenant Medical Center Inc. - Form 483R, 2011-05-10
August, 2012 EIR Satyaprakash N. Makam, MD - EIR, 2012-08-29
November, 2015 EIR Fahd Al-Saghir, MD - EIR, 2015-11-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more